Abstract
‘Acid’ β-glucosidase of human spleen, from either normal controls or patients with type 1 (adult) Gaucher disease, was incorporated into phosphatidylcholine liposomes. The non-incorporated (soluble) Gaucherenzyme had a higher apparent molecular weight than had the corresponding control. Liposomal ‘acid’ β-glucosidase prepared from Gaucher-spleen was more thermostable than was the corresponding normal enzyme; it was also stimulated by acidic lipids to a much lesser extent. The results suggest that the genetic mutation in type 1 (adult) Gaucher disease has multiple effects on the glycoprotein form of ‘acid’ β-glucosidase.
Similar content being viewed by others
References
Barnes, J. and Clague, A. E. An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-β-D-glucopyranoside.Clin. Chim. Acta 120 (1982) 57–63
Beck, C. and Tappel, A. L. Rat-liver lysosomal β-glucosidase: a membrane enzyme.Biochim. Biophys. Acta 151 (1968) 147–158
Brady, R. O. and Barranger, J. A. Glucosylceramide lipidosis: Gaucher's disease. In Stanbury, J. B., Wyngaarden, J. B., Frederickson, D. S., Goldstein, J. L. and Brown, M. S. (eds.)The Metabolic Basis of Inherited Disease, 5th edn., McGraw-Hill, New York, 1983, pp. 842–856
Carroll, M. Incorporation of ‘acid’ β-glucosidase into phosphatidylcholine liposomes.Trans. Biochem. Soc. (1984) (In press)
Folch, J., Lees, M. and Sloane Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 226 (1957) 497–509
Gatt, S., Dinur, T. and Desnick, R. J. Studies on human acid β-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.Prog. Clin. Biol. Res. 95 (1982) 315–331
Ginns, E. I., Brady, R. O., Pirrucello, S., Moore, C., Sorrell, S., Furbish, F. S., Murray, G. J., Tager, J. and Barranger, J. A. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 5607–5610
Glew, R. H., Daniels, L. B., Clark, L. S. and Hoyer, S. W. Enzymic differentiation of neurologic and non-neurologic forms of Gaucher's disease.J. Neuropathol. Exp. Neurol. 41 (1982) 630–641
Ho, M. W. and Light, N. D. Glucocerebrosidase: reconstitution from macromolecular components depends on acidic phospholipids.Biochem. J. 136 (1973) 821–823
Kagawa, Y. and Racker, E. Partial resolution of the enzymes catalyzing oxidative phosphorylation.J. Biol. Chem. 246 (1971) 5477–5487
Karazeh, A. and Carroll, M. Physical and kinetic properties of β-glucosidase in Gaucher disease.J. Inher. Metab. Dis. 6 (1983) 101–104
Okada, S. and O'Brien, J. S. Tay-Sachs disease: generalized absence of anN-acetyl-β-D-glucosaminidase component.Science 165 (1969) 698–700
Pentchev, P. G., Brady, R. O., Blair, H. E., Britton, D. E. and Sorrell, S. H. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 3970–3973
Pentchev, P. G., Neumeyer, B., Svennerholm, L., Groth, C. G. and Brady, R. O. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.Am. J. Hum. Genet. 35 (1983) 621–628
Peters, S. P., Coyle, P., Coffee, C. J., Glew, R. H., Kuhlenschmidt, M. S., Rosenfeld, L. and Lee, Y. C. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.J. Biol. Chem. 252 (1977) 563–573
Yaqoob, M. and Carroll, M. Isoenzymes of membrane-bound β-glucosidase of human spleen.Biochem. J. 185 (1980) 541–543
Yaqoob, M. and Carroll, M. Multiple forms of membrane-bound β-glucosidase in Gaucher's disease.Clin. Genet. 20 (1981) 161–167
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carroll, M. Gaucher disease (type 1): Physical and kinetic properties of liposomal and soluble ‘acid’ β-glucosidase. J Inherit Metab Dis 8, 33–37 (1985). https://doi.org/10.1007/BF01805482
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01805482